Pharmacy regulator to publish ‘diversity data’ around fitness-to-practise cases The General Pharmaceutical Council has said it will publish diversity data related to fitness-to-practise cases in order to understand and address potential discrimination.…
Genes associated with most severe form of COVID-19 identified Researchers have identified five genes associated with COVID-19 and used their findings to predict the effect of drug treatments on patients.…
Pharmacists added to government’s list of occupations facing national shortage The inclusion of pharmacists in the shortage occupation list means staff from abroad can apply for a skilled worker visa through the UK’s immigration system more easily.…
Government to consider PrEP provision outside of sexual health clinics Exclusive: The government says access to pre-exposure prophylaxis for HIV could be expanded to community pharmacies and GP practices.…
£1.8m-per-dose gene therapy approved for NHS use in Scotland The single-dose treatment for spinal muscular atrophy could also become the most expensive drug to ever be approved by NICE for use in England and Wales.…
Working to improve our digital archive Now that the new platform has launched, we are moving across our digital archive in stages to ensure it is presented in the best way possible.…
RECOVERY trial halts recruitment to colchicine arm because of a lack of ‘convincing’ evidence The anti-inflammatory drug colchicine has shown no significant difference in improving survival rates from usual care in patients with COVID-19.…
RPS Museum online exhibition celebrates women in pharmacy 'Celebrating Women in Pharmacy' launched on International Women's Day and celebrates women throughout the history of pharmacy.…
Government will ‘prioritise’ extending valproate registry to cover all antiepileptic drugs The Department of Health and Social Care said that it will prioritise extending the valproate registry to include all women prescribed an antiepileptic drug.…
Almost 3,000 candidates to sit March 2021 registration assessment The General Pharmaceutical Council has said that the “vast majority” of candidates in Great Britain will be able to sit the assessment within 50 miles of their home address.…
